18 F]FDG-PET/CT in a 40-year-old woman with previous breast cancer
By A Mystery Man Writer
Description
Cancers, Free Full-Text
Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy, Radiation Oncology
Clinical impact of 18F-FDG PET/CT on initial staging and therapy planning for breast cancer
COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management
Correlation of primary tumor metabolic parameters with clinical, histopathological and molecular characteristics in breast cancer patients at pre-operative staging FDG-PET/CT study, Egyptian Journal of Radiology and Nuclear Medicine
Low-dose PEM shows promise in breast cancer detection
Role of 18F-FDG PET/CT in evaluation of recently diagnosed breast cancer patients, Egyptian Journal of Radiology and Nuclear Medicine
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing
HER2-Positive Breast Cancer: Tumor-to-Liver SUV Ratio is the Best Parameter for Detection in F-18 FDG-PET/CT, IJ Radiology
JCM, Free Full-Text
False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer - ScienceDirect
18F-FDG PET/CT surveillance at 3–6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation
from
per adult (price varies by group size)